Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (1795)	1/22/2008 4:06:14 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

CGPI Is 5.44% with volume > 2x its ADV. The stock had already closed its Sep26 DG & is now trading above its Oct-Jan Hs. stockcharts.com It announced today results of a dose-comparison study designed to evaluate the safety and efficacy of a daily dose of its Oracea vs. doxycycline 100 mg also daily, for the treatment of rosacea. A presentation was made yesterday at the 7th Annual Caribbean Dermatology Symposium. CGPI trades around 3.7xBV with a negative CF around $1.55 The insiders did some buying in Nov. The short ratio came down about 5% & is still around 3.5x its ADV The stock is now almost getting off the DT coming from its Feb H at $15.75 Bernard